Concepedia

Cansu Karakaş

CK

21

Publications

1.3K

Citations

17

H-Index

2003

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

University of Nottingham

University of Rochester Medical Center

University of Rochester

Cansu Karakaş is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2003–2024

21

Publications

21

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

Smruthi Vijayaraghavan, Cansu Karakaş, Iman Doostan et al. · Nature Communications · 2017 · 272 citations · Full text

Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer

Jason P.W. Carey, Cansu Karakaş, Tuyen Bui et al. · Cancer Research · 2017 · 140 citations · Full text

, , +19

Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition

Xian Chen, Kwang-Huei Low, Angela Alexander et al. · Clinical Cancer Research · 2018 · 110 citations · Full text

Paget′s disease of the breast

Cansu Karakaş · Journal of Carcinogenesis · 2011 · 99 citations · Full text

, , +12

A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer

Zahi Mitri, Cansu Karakaş, Caimiao Wei et al. · Investigational New Drugs · 2015 · 88 citations

, , +9

Rows per page

1–5 of 21